Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tevogen Bio Inc
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 31, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
May 30, 2026
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 29, 2026
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
May 27, 2026
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
May 22, 2026
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 22, 2026
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
May 22, 2026
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
May 20, 2026
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
May 19, 2026
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
May 19, 2026
1
2
Next Page
→